Paradise Valley, AZ1 Active Studies

Myasthenia Gravis Clinical Trials in Paradise Valley, AZ

Find 1 actively recruiting myasthenia gravis clinical trials in Paradise Valley, AZ. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
199
Enrolling

Recruiting Myasthenia Gravis Studies in Paradise Valley

About Myasthenia Gravis Clinical Trials in Paradise Valley

Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the skeletal muscles responsible for breathing and movement. It occurs when communication between nerves and muscles is disrupted. Treatment includes medications that improve neuromuscular transmission and immunosuppressive therapies.

There are currently 1 myasthenia gravis clinical trials recruiting participants in Paradise Valley, AZ. These studies are seeking a combined 199 participants. Research is being sponsored by Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myasthenia Gravis Clinical Trials in Paradise Valley — FAQ

Are there myasthenia gravis clinical trials in Paradise Valley?

Yes, there are 1 myasthenia gravis clinical trials currently recruiting in Paradise Valley, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Paradise Valley?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Paradise Valley research site will contact you about next steps.

Are clinical trials in Paradise Valley free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Paradise Valley studies also compensate for your time and travel.

What myasthenia gravis treatments are being tested?

The 1 active trials in Paradise Valley are testing new therapies including novel drugs, biologics, and treatment approaches for myasthenia gravis.

Data updated July 13, 2026 from ClinicalTrials.gov